MADD: Multi-Agent Drug Discovery Orchestra
Open Access
- 1 January 2025
- conference paper
- Published by Association for Computational Linguistics (ACL)
- p. 6956-6998
Abstract
Gleb Vitalevich Solovev, Alina Borisovna Zhidkovskaya, Anastasia Orlova, Nina Gubina, Anastasia Vepreva, Rodion Golovinskii, Ilya Tonkii, Ivan Dubrovsky, Ivan Gurev, Dmitry Gilemkhanov, Denis Chistiakov, Timur A. Aliev, Ivan Poddiakov, Galina Zubkova, Ekaterina V. Skorb, Vladimir Vinogradov, Alexander Boukhanovsky, Nikolay Nikitin, Andrei Dmitrenko, Anna Kalyuzhnaya, Andrey Savchenko. Findings of the Association for Computational Linguistics: EMNLP 2025. 2025.Keywords
All Related Versions
This publication has 33 references indexed in Scilit:
- Exploring the future of biopharmaceutical drug discovery: can advanced AI platforms overcome current challenges?Discover Artificial Intelligence, 2024
- De novo drug design as GPT language modeling: large chemistry models with supervised and reinforcement learningJournal of Computer-Aided Molecular Design, 2024
- Deep Generative Models in De Novo Drug Molecule GenerationJournal of Chemical Information and Modeling, 2023
- Deep generative molecular design reshapes drug discoveryCell Reports Medicine, 2022
- MGCVAE: Multi-Objective Inverse Design via Molecular Graph Conditional Variational AutoencoderJournal of Chemical Information and Modeling, 2022
- Generative Chemical Transformer: Neural Machine Learning of Molecular Geometric Structures from Chemical Language via AttentionJournal of Chemical Information and Modeling, 2021
- Reinforced Adversarial Neural Computer for de Novo Molecular DesignJournal of Chemical Information and Modeling, 2018
- Bempedoic Acid (ETC-1002): an Investigational Inhibitor of ATP Citrate LyaseCurrent Atherosclerosis Reports, 2016
- Feedback Activation of STAT3 as a Cancer Drug-Resistance MechanismTrends in Pharmacological Sciences, 2016
- Revisiting STAT3 signalling in cancer: new and unexpected biological functionsNature Reviews Cancer, 2014